Building business partnerships in human and animal health

Parties with an interest to tackle major challenges related to infectious diseases in both humans and animals, in collaboration with appropriate business partners, turn to Immuno Valley. We effectively match business and science to specifically build, nurture, and support lasting business partnerships for R&D. Read more about How We Work>

Contact us

Interested in Immuno Valley Network or Services? 
Call us: +31 (0) 30 253 1142
Send an email:



  1. Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger

    A new, heat-stable vaccine is safe and effective against rotavirus, according to results of a recent Doctors Without Borders/Médecins Sans Frontiéres vaccine trial in Niger, published in the New England Journal of Medicine. Read more...

  2. Immune study in chickens reveals key hurdle for Campylobacter vaccine effort

    New University of Liverpool research reveals that the immune response of farmed chickens does not develop fast enough to fight off Campylobacter during their short lifespan. The findings have important implications in the challenge towards developing a poultry vaccine for the bug, which is the UK's leading cause of food poisoning. Read more...

  3. Infravec2 project launch: A European Commission €10m effort to fight mosquito-transmitted diseases

    The European Commission officially approved the Infravec2 project (Research Infrastructures for the control of vector-borne diseases). This project will improve the European large-scale facilities for research on mosquitoes and other insects (vectors) that carry human and animal  diseases, and will promote sharing of the facilities by European researchers. Read more...

More news


  1. 4th Microbiome R&D and Business Collaboration Forum: Europe

    As part of its worldwide microbiome series, Global Engage is pleased to announce the Microbiome R&D and Business Collaboration Forum: Europe.

  2. Microbiome, Immune Function and Allergic Disease

    Microbiome, Immune Function and Allergic Disease lecture by Nicholas Lukacs

  3. Netherlands Antibiotic Development Platform launch event

    On 18 April 2017, the official launch of the NADP will take place in Utrecht, the Netherlands.

  4. General Assembly of Flanders Vaccine & Academia-Industry Connect Meeting

    We kindly invite you to the “Academia-Industry Connect Meeting”, taking place on April 18th, 2017 in Leuven.